Differentiated neurons were treated with 0.5 mM glutamate for 2 h and immunostained with anti-tau (Tau-5), anti-tau pSer199, anti-tau pSer396 or anti-AT8 antibody – a known AD-relevant epitope – and anti-MAP2 antibody as a dendritic marker. This evidence concerns the gene MAP2 and Alzheimer disease.